Why Bloom Energy Corporation (BE) stock moved
Bloom Energy Corporation (BE) shares tumbled 9.3% to $244.43 as of July 8, 2026, a significant decline from the prior close of $269.57. BestStocks flagged the session as a major change for BE. Below, we break down what changed for BE, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
BE fell 9.3% to $244.43
Bloom Energy Corporation moved -8.96% intraday from $269.57 to $245.41. Prediction: Why Buying Brookfield Renewable Instead of Bloom ...: That's why Bloom Energy's product backlog rose 2.5x year over year to $6 billion at the start of 2026. But that's just the start of the story, because each new ... That's why Bloom Energy's product backlog rose 2.5x year [2026-07-07] Monitor for follow-through at the close.
What it means for Bloom Energy Corporation investors
For Bloom Energy Corporation investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Sharp 9.3% decline — elevated risk; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $259.00, implying +6.0% upside from $244.43. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 20 days out, the next report is the most likely near-term test of the move.
BE price reaction
BE last traded at $244.43, down $25.14 (-9.33%) from the previous close of $269.57. The session traded on 1.1× average volume (normal), so participation was unremarkable.
Bullish and bearish analyst opinions on Bloom Energy Corporation (BE)
The consensus analyst price target on Bloom Energy Corporation (BE) is $259.00, 6.0% above the recent $244.43. Over the past 90 days analysts logged 1 upgrade, 19 maintains, and 0 downgrades. Here is how the bullish and bearish cases on BE line up.
The bullish case
- Wall Street's consensus price target of $259.00 implies +6.0% upside from $244.43.
- The Street's most bullish target is $350.00 (+43.2%).
- 1 analyst upgrade in the past 90 days, most recently Jefferies to Hold (2026-04-14).
- Positive price momentum.
The bearish case
- The most bearish analyst target is $68.00 (-72.2%).
- Sharp 9.3% decline — elevated risk.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 8, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for BE
Frequently asked questions about BE
Why did Bloom Energy Corporation (BE) stock move?
BE tumbled 9.3% to $244.43. The move is tied to the catalyst and context summarized above, not unexplained technical trading.
How much did BE stock fall?
BE lost 9.33% ($25.14) versus the prior close of $269.57, last trading at $244.43 on 1.1× average volume.
When is Bloom Energy Corporation's next earnings date?
BE's next earnings report is estimated for 2026-07-28 — about 20 days away.
What is the analyst price target for BE?
The consensus analyst price target for BE is $259.00, about 6.0% above the current $244.43. Over the past 90 days, analysts recorded 1 upgrade, 19 maintains, and 0 downgrades.
How BestStocks tracks BE
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared BE-specific materiality thresholds, triggering an evidence check. It draws on 10 tracked change events for BE, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 8, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.